• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注意缺陷多动障碍患病率的系统评价和荟萃分析。

Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.

机构信息

Centre for Research in Evidence-Based Practice (CREBP), Faculty of Health Sciences and Medicine, Bond University, Queensland, Australia

Centre for Research in Evidence-Based Practice (CREBP), Faculty of Health Sciences and Medicine, Bond University, Queensland, Australia.

出版信息

Pediatrics. 2015 Apr;135(4):e994-1001. doi: 10.1542/peds.2014-3482. Epub 2015 Mar 2.

DOI:10.1542/peds.2014-3482
PMID:25733754
Abstract

BACKGROUND AND OBJECTIVE

Overdiagnosis and underdiagnosis of attention-deficit/hyperactivity disorder (ADHD) are widely debated, fueled by variations in prevalence estimates across countries, time, and broadening diagnostic criteria. We conducted a meta-analysis to: establish a benchmark pooled prevalence for ADHD; examine whether estimates have increased with publication of different editions of the Diagnostic and Statistical Manual of Mental Disorders (DSM); and explore the effect of study features on prevalence.

METHODS

Medline, PsycINFO, CINAHL, Embase, and Web of Science were searched for studies with point prevalence estimates of ADHD. We included studies of children that used the diagnostic criteria from DSM-III, DSM-III-R and DSM-IV in any language. Data were extracted on sampling procedure, sample characteristics, assessors, measures, and whether full or partial criteria were met.

RESULTS

The 175 eligible studies included 179 ADHD prevalence estimates with an overall pooled estimate of 7.2% (95% confidence interval: 6.7 to 7.8), and no statistically significant difference between DSM editions. In multivariable analyses, prevalence estimates for ADHD were lower when using the revised third edition of the DSM compared with the fourth edition (P = .03) and when studies were conducted in Europe compared with North America (P = .04). Few studies used population sampling with random selection. Most were from single towns or regions, thus limiting generalizability.

CONCLUSIONS

Our review provides a benchmark prevalence estimate for ADHD. If population estimates of ADHD diagnoses exceed our estimate, then overdiagnosis may have occurred for some children. If fewer, then underdiagnosis may have occurred.

摘要

背景与目的

注意力缺陷多动障碍(ADHD)的过度诊断和漏诊现象广泛存在争议,这主要是由于不同国家、不同时间以及诊断标准的不断放宽导致患病率估计值存在差异。我们进行了一项荟萃分析,旨在:建立 ADHD 的基准汇总患病率;检查不同版本的《精神障碍诊断与统计手册》(DSM)出版后,估计值是否有所增加;并探讨研究特征对患病率的影响。

方法

我们在 Medline、PsycINFO、CINAHL、Embase 和 Web of Science 上搜索了有关 ADHD 时点患病率估计值的研究。我们纳入了使用 DSM-III、DSM-III-R 和 DSM-IV 诊断标准的任何语言的儿童研究。我们提取了关于抽样程序、样本特征、评估者、测量方法以及是否满足全部或部分标准的信息。

结果

符合条件的 175 项研究共纳入了 179 项 ADHD 患病率估计值,总体汇总患病率为 7.2%(95%置信区间:6.7 至 7.8),不同 DSM 版本之间无统计学差异。在多变量分析中,与第四版相比,使用修订后的第三版 DSM 时 ADHD 的患病率估计值较低(P=0.03),而在欧洲进行的研究与在北美进行的研究相比(P=0.04),患病率估计值也较低。很少有研究采用随机选择的人群抽样。大多数研究来自单一城镇或地区,因此限制了其普遍性。

结论

我们的综述提供了 ADHD 的基准患病率估计值。如果 ADHD 的人群诊断估计值超过我们的估计值,那么可能对某些儿童出现了过度诊断。如果诊断较少,则可能出现漏诊。

相似文献

1
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.注意缺陷多动障碍患病率的系统评价和荟萃分析。
Pediatrics. 2015 Apr;135(4):e994-1001. doi: 10.1542/peds.2014-3482. Epub 2015 Mar 2.
2
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
3
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
4
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
5
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的多不饱和脂肪酸(PUFA)
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007986. doi: 10.1002/14651858.CD007986.pub2.
6
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
7
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
8
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.
9
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
10
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.患有共病抽动障碍的儿童注意力缺陷多动障碍(ADHD)的药物治疗。
Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3.

引用本文的文献

1
Association between attention deficit hyperactivity disorder and bruxism: A systematic review protocol.注意缺陷多动障碍与磨牙症之间的关联:一项系统评价方案
PLoS One. 2025 Sep 11;20(9):e0331581. doi: 10.1371/journal.pone.0331581. eCollection 2025.
2
The Interplay of Family Dynamics, Lifestyle, and ADHD: A Case-Control Study on Sociodemographic Risk Factors.家庭动态、生活方式与注意力缺陷多动障碍的相互作用:一项关于社会人口学风险因素的病例对照研究
Brain Behav. 2025 Sep;15(9):e70830. doi: 10.1002/brb3.70830.
3
Exploring the Role of Turbinate Reduction in Alleviating Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Pediatric Patients.
探索下鼻甲缩小术在缓解小儿患者注意力缺陷多动障碍(ADHD)症状中的作用。
Cureus. 2025 Jul 26;17(7):e88807. doi: 10.7759/cureus.88807. eCollection 2025 Jul.
4
Associations between dietary inflammatory index (DII) scores and attention deficit hyperactivity disorder (ADHD) in children.儿童饮食炎症指数(DII)得分与注意力缺陷多动障碍(ADHD)之间的关联。
Sci Rep. 2025 Aug 22;15(1):30884. doi: 10.1038/s41598-025-08919-x.
5
P300 event-related potentials as diagnostic biomarkers for attention deficit hyperactivity disorder in children.P300事件相关电位作为儿童注意力缺陷多动障碍的诊断生物标志物
Front Psychiatry. 2025 Aug 5;16:1590850. doi: 10.3389/fpsyt.2025.1590850. eCollection 2025.
6
Prevalence of Attention-Deficit Hyperactivity Disorder (ADHD) in Iranian Elementary School Children: A Systematic Review and Meta-Analysis.伊朗小学生注意力缺陷多动障碍(ADHD)的患病率:一项系统评价和荟萃分析。
Child Psychiatry Hum Dev. 2025 Aug 14. doi: 10.1007/s10578-025-01899-z.
7
Objective diagnosis of attention-deficit/hyperactivity disorder by using load cell movement analysis under a smart chair in a simulated classroom: influence of sex and age.在模拟教室中通过智能椅子下的称重传感器运动分析对注意力缺陷/多动障碍进行客观诊断:性别和年龄的影响
J Neurodev Disord. 2025 Aug 12;17(1):46. doi: 10.1186/s11689-025-09641-5.
8
Brain structure characteristics in children with attention-deficit/hyperactivity disorder elucidated using traveling-subject harmonization.采用受试者移动归一化法阐明注意缺陷多动障碍儿童的脑结构特征
Mol Psychiatry. 2025 Aug 8. doi: 10.1038/s41380-025-03142-6.
9
Facilitating sleep initiation in children with ADHD and sleep problems: a qualitative experience-based study.促进多动症和睡眠问题儿童的入睡:一项基于经验的定性研究。
BMC Pediatr. 2025 Aug 7;25(1):609. doi: 10.1186/s12887-025-05964-3.
10
Challenges in amphetamine medication availability for individuals with ADHD: a narrative review of the current state of evidence.多动症患者使用苯丙胺类药物的可及性挑战:证据现状的叙述性综述
Front Psychiatry. 2025 Jul 23;16:1624590. doi: 10.3389/fpsyt.2025.1624590. eCollection 2025.